Subclassification of pathologically organ-confined (pT2) prostate cancer does not significantly predict postoperative outcomes in Korean males

Subclassification of pathologically organ-confined (pT2) prostate cancer does not significantly predict postoperative outcomes in Korean males

Purpose: We evaluated the prognostic association of pT2 subclassification with the oncological outcomes in patients with prostate cancer (PCa) who underwent radical prostatectomy (RP) in South Korea. Materials and Methods: We retrospectively reviewed 3,529 patients who underwent RP for pathologicall...

Full description

Bibliographic Details
Main Authors:	Min Ho Lee, Sangchul Lee, Sung Kyu Hong, Seok-Soo Byun, Sang Eun Lee
Format:	Article
Language:	English
Published:	Korean Urological Association 2020-01-01
Series:	Investigative and Clinical Urology
Subjects:	pathology prognosis prostate neoplasms prostatectomy recurrence
Online Access:	https://www.icurology.org/Synapse/Data/PDFData/2020ICU/icu-61-35.pdf

Similar Items

Prognostic value of subclassification (pT2 stage) of pathologically organ-confined prostate cancer: Confirmation of the changes introduced in the 8th edition of the American Joint Committee on Cancer (AJCC) staging system
by: Hugo Pontes Antunes, et al.
Published: (2018-09-01)

Prediction of pathologic upgrading in Gleason score 3+4 prostate cancer: Who is a candidate for active surveillance?
by: Duc Minh Pham, et al.
Published: (2020-07-01)

Preoperative prostate health index and %p2PSA as the significant biomarkers of postoperative pathological outcomes of prostate cancer in Korean males: A prospective multi-institutional study
by: Hongzoo Park, et al.
Published: (2020-01-01)

Significance of the correlation between serum-prostate specific antigen and the percentage of prostate cancer volume in postoperative biochemical progression
by: Spasić Aleksandar, et al.
Published: (2017-01-01)

Risk stratification for disease progression in pT3 prostate cancer after robot-assisted radical prostatectomy
by: Jeong Hee Hong, et al.
Published: (2017-01-01)

Clinical Significance of Serum Adipokines according to Body Mass Index in Patients with Clinically Localized Prostate Cancer Undergoing Radical Prostatectomy
by: Minyong Kang, et al.
Published: (2018-01-01)

Prostate-specific antigen density predicts favorable pathology and biochemical recurrence in patients with intermediate-risk prostate cancer
by: Ho Won Kang, et al.
Published: (2016-01-01)

Correlation between postoperative prostate-specific antigen and biochemical recurrence in positive surgical margin patients: Single surgeon series
by: Won Ik Seo, et al.
Published: (2017-06-01)

Improvement of the surgical curability of locally confined prostate cancer including non-organ-confined high-risk disease through retropubic radical prostatectomy with intentional wide resection
by: Okajima Eijiro, et al.
Published: (2012-11-01)

Analysis of expanded criteria to select candidates for active surveillance of low-risk prostate cancer
by: Jung Ki Jo, et al.
Published: (2015-04-01)

Difference between actual vs. pathology prostate weight in TURP and radical robotic-assisted prostatectomy specimen
by: Szilveszter Lukacs, et al.
Published: (2014-12-01)

PROGNOSTIC FACTORS OF PROSTATE CANCER SYSTEMIC PROGRESSION IN PATIENTS WITH BIOCHEMICAL RECURRENCE AFTER RADICAL PROSTATECTOMY
by: P. D. Demeshko, et al.
Published: (2014-07-01)

PROGNOSTIC FACTORS OF PROSTATE CANCER SYSTEMIC PROGRESSION IN PATIENTS WITH BIOCHEMICAL RECURRENCE AFTER RADICAL PROSTATECTOMY
by: P. D. Demeshko, et al.
Published: (2014-07-01)

Immunophenotype Rearrangement in Response to Tumor Excision May Be Related to the Risk of Biochemical Recurrence in Prostate Cancer Patients
by: Paulius Bosas, et al.
Published: (2021-08-01)

Clinical significance and risk factors of International Society of Urological Pathology (ISUP) grade upgrading in prostate cancer patients undergoing robot-assisted radical prostatectomy
by: Yuta Takeshima, et al.
Published: (2021-05-01)

Salvage radiotherapy of prostate cancer recurrences after radical prostatectomy
by: S. I. Tkachev, et al.
Published: (2018-04-01)

CRTC2 as a novel prognostic biomarker for worse pathologic outcomes and biochemical recurrence after radical prostatectomy in patients with prostate cancer
by: Hakmin Lee, et al.
Published: (2019-03-01)

Degree of Preservation of Neurovascular Bundles in Radical Prostatectomy and Recurrence of Prostate Cancer
by: Elin Axén, et al.
Published: (2021-08-01)

Use of Testosterone Replacement Therapy after Radical Prostatectomy Might Kill Two Birds with One Stone from the Perspective of Men’s Health and Disease Control
by: Jong Kil Nam, et al.
Published: (2020-07-01)

Conditional biochemical recurrence-free survival after radical prostatectomy in patients with high-risk prostate cancer
by: Sung-Woo Park, et al.
Published: (2020-12-01)

Detecting recurrent prostate Cancer using multiparametric MRI, influence of PSA and Gleason grade
by: Aradhana M. Venkatesan, et al.
Published: (2021-01-01)

Transurethral resection of the prostate is an independent risk factor for biochemical recurrence after radical prostatectomy for prostate cancer
by: Kun Jin, et al.
Published: (2020-01-01)

Does a previous prostate biopsy-related acute bacterial prostatitis affect the results of radical prostatectomy?
by: Hakan Türk, et al.

Editorial: Controversies and Perspectives in the Use of Postoperative Radiotherapy for Prostate Cancer
by: Alan Dal Pra, et al.
Published: (2017-11-01)

Prognostic Relevance of Methylenetetrahydrofolate Reductase Polymorphisms for Prostate Cancer
by: Victor C. Lin, et al.
Published: (2016-11-01)

Can microfocal prostate cancer be regarded as low-risk prostate cancer?
by: Seung Hwan Lee, et al.
Published: (2013-12-01)

Retrospective study on the benefit of adjuvant radiotherapy in men with intraductal carcinoma of prostate
by: Vincent Q. Trinh, et al.
Published: (2019-04-01)

Oncological outcomes following radical prostatectomy for patients with pT4 prostate cancer
by: Dharam Kaushik, et al.

Statins Prevent Biochemical Recurrence of Prostate Cancer After Radical Prostatectomy: A Single-center Retrospective Study with a Median Follow-up of 51.20 Months
by: Jarimba R, et al.
Published: (2020-09-01)

Large-cell neuroendocrine tumor of the prostate: a case report and review of the literature
by: Walid Sleiman, et al.
Published: (2021-05-01)

Contemporary trends in radical prostatectomy and predictors of recovery of urinary continence in men aged over 70 years: comparisons between cohorts aged over 70 and less than 70 years
by: Young Ju Lee, et al.
Published: (2020-01-01)

High-risk prostate cancer: factors predicting biochemical recurrence after radical prostatectomy
by: Albertas Ulys, et al.
Published: (2015-12-01)

Analysis of factors affecting first serum prostate specific antigen level after radical prostatectomy for prostate cancer
by: ZHANG Jingqi, et al.
Published: (2019-08-01)

Upgrading and upstaging of low-risk prostate cancer among Korean patients: a multicenter study
by: Insang Hwang, et al.
Published: (2015-01-01)

Biochemical recurrence after radical prostatectomy: is the disease or the surgeon to blame?
by: Adnan Simsir, et al.
Published: (2011-06-01)

Management of Biochemical Recurrence after Primary Localized Therapy for Prostate Cancer
by: Oussama M. eDarwish, et al.
Published: (2012-05-01)

Preoperative erectile function and the pathologic features of prostate cancer
by: Chang Wook Jeong, et al.
Published: (2015-04-01)

Fear of Recurrence in Prostate Cancer Patients: A Cross-sectional Study After Radical Prostatectomy or Active Surveillance
by: Rasmus Nilsson, et al.
Published: (2021-03-01)

Efficacy of PSMA ligand PET-based radiotherapy for recurrent prostate cancer after radical prostatectomy and salvage radiotherapy
by: Ann-Kathrin Oehus, et al.
Published: (2020-04-01)

Preoperative PROSTATE scoring system: a potential predictive tool for the risk of biochemical recurrence after radical prostatectomy
by: Zhang ZN, et al.
Published: (2018-10-01)